ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
This Quarter Return
-4.76%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$86.2M
AUM Growth
+$86.2M
Cap. Flow
-$1.2M
Cap. Flow %
-1.39%
Top 10 Hldgs %
64.54%
Holding
46
New
7
Increased
19
Reduced
6
Closed
12
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ZYME icon
26
Zymeworks
ZYME
$1.12B
$815K 0.95% 68,459 +1,219 +2% +$14.5K
RARE icon
27
Ultragenyx Pharmaceutical
RARE
$2.89B
$771K 0.89% 21,290 +290 +1% +$10.5K
VERV
28
DELISTED
Verve Therapeutics
VERV
$744K 0.86% 162,724 +2,524 +2% +$11.5K
RCKT icon
29
Rocket Pharmaceuticals
RCKT
$354M
$556K 0.64% 83,350 -51,150 -38% -$341K
RAPP
30
Rapport Therapeutics
RAPP
$643M
$164K 0.19% 16,400
FBRX icon
31
Forte Biosciences
FBRX
$137M
$143K 0.17% 18,469 +330 +2% +$2.56K
ARTV
32
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$76.7M
$136K 0.16% 45,456 +1,456 +3% +$4.37K
NUVB.WS icon
33
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$68M
$17.5K 0.02% 90,832
PCVX icon
34
Vaxcyte
PCVX
$4B
-45,000 Closed -$3.68M
SGMO icon
35
Sangamo Therapeutics
SGMO
$157M
-740,000 Closed -$755K
THRD
36
DELISTED
Third Harmonic Bio
THRD
-49,800 Closed -$512K
TSHA icon
37
Taysha Gene Therapies
TSHA
$797M
-884,244 Closed -$1.53M
TECX
38
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
-33,008 Closed -$1.52M
ACLX icon
39
Arcellx
ACLX
$3.85B
-10,743 Closed -$824K
CELC icon
40
Celcuity
CELC
$2.17B
-25,000 Closed -$327K
CRNX icon
41
Crinetics Pharmaceuticals
CRNX
$2.92B
-122,900 Closed -$6.28M
CRVS icon
42
Corvus Pharmaceuticals
CRVS
$428M
-74,307 Closed -$398K
ELDN icon
43
Eledon Pharmaceuticals
ELDN
$155M
-235,750 Closed -$971K
MRSN icon
44
Mersana Therapeutics
MRSN
$36.5M
-1,120,500 Closed -$1.6M
NAMS icon
45
NewAmsterdam Pharma
NAMS
$2.71B
-50,000 Closed -$1.29M